ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Data Note
Revised

CD4+ T-cell transcription factors as early predictors of phenoconversion in idiopathic rapid eye movement sleep behaviour disorder

[version 2; peer review: 1 approved, 1 approved with reservations]
Previously titled: The importance of early biomarkers in the identification of neurodegenerative disorders
PUBLISHED 06 Oct 2025
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Cell & Molecular Biology gateway.

This article is included in the Bioinformatics gateway.

This article is included in the Retinal Physiology collection.

Abstract

In this datanote we present data from 31 iRBD (idiopathic Rapid eye movement (REM) sleep Behaviour Disorder) patients followed throughout three years to assess their eventual phenoconversion to Parkinson’s disease and other established neurodegenerative conditions. iRBD is a prodromal condition of neurological pathologies such as Parkinson’s disease. We evaluated transcription factor mRNA levels in CD4+ T cells as predictive biomarkers of phenoconversion in iRBD, showing that among the transcription factors mRNA levels analysed, STAT1, GATA3 and FOXP3 mRNA levels may be used to predict phenoconversion. In particular, we found that CD4+ T cells from converters had higher STAT1, and lower GATA3 and FOXP3 mRNA levels. According to ROC curve analysis STAT1 levels provided a good discrimination, GATA3 levels an excellent discrimination of future converters and not-converters, while discrimination provided by FOXP3 levels was acceptable.

Keywords

Early biomarkers, neurodegenerative disorders, Parkinson’s disease; CD4+ T lymphocytes; Transcription factors; Gene expression

Revised Amendments from Version 1

In the present version, the title has been modified to make it more consistent with the content of the study, the abstract has been expanded to include a summary of the main results and the introduction has been reworked to better highlight the innovative nature of the research ad its connection to our previous publications.

See the authors' detailed response to the review by Tommaso Schirinzi
See the authors' detailed response to the review by Adawiya J. Haider

Introduction

Rapid eye movement (REM) sleep behaviour disorder (RBD) is a REM-phase parasomnia, typically associated with neurodegenerative disorders (38-75%1,2). iRBD (idiopathic Rapid eye movement (REM) sleep Behaviour Disorder) is a prodromal condition in the process underlying synucleinopathies, including Parkinson’s disease (PD). The risk for PD conversion in people with iRBD is estimated around 43% at five years.3

The data included here are from a study3 that evaluated whether transcription factor genes TBX21, STAT1, STAT3, STAT4, STAT6, RORC, GATA3, FOXP3, and NR4A2 mRNA levels in CD4+ T cells could represent predictive biomarkers of phenoconversion in iRBD patients. To this end, we performed a follow-up of the iRBD subjects enrolled in previous research,4 with the aim to identify three years later who was eventually phenoconverted towards a frank neurodegenerative condition. The study by Di Francesco et al. (2021)4 showed that in iRBD subjects CD4+ T cells exhibit a peculiar molecular signature strongly resembling cells from PD patients, while the study by Pinoli et al. (2024)5 thereafter revealed that STAT1, GATA3 and FOXP3 mRNA levels in CD4+ T cells are promising predictive biomarkers of phenoconversion in iRBD patients.

Indeed, converters showed higher expression levels of STAT1, and lower levels of GATA3 and FOXP3. We also found higher percentages of monocytes in converters versus not converters. The implications of these transcription factors in the neuroinflammatory process are clearly evinced also from the contribution they make to the differentiation of Th1 (STAT1), Th2 (GATA3) and Treg (FOXP3) phenotypes. Namely, it was demonstrated that peripheral blood of PD patients had increased Th1 and decreased Th2 and Treg.6

We decided to focus on the study of molecular markers to identify early variations that could allow us to identify individuals who will develop PD, before lesions develop. Future studies will be necessary to further explore the role of these markers and subsequently develop targeted drugs for tailored therapy.

Data reported in this paper have been previously analysed in Pinoli et al. (2024) and De Francesco et al. (2021).

Materials and methods

Ethical statement

The Ethics Committee of the Neurological Institute “C. Mondino” of Pavia approved the protocol (number 2021008499, 10/02/2021) and all the participants signed a written informed consent before enrolment.

Participants

31 patients were followed at the Sleep Center of the Neurological Institute “C. Mondino” of Pavia. The clinical evaluation included: motor symptoms, assessed by means of the Unified Parkinson’s Disease Rating Scale (UPDRS) part III7; cognitive function, by the Mini Mental State Examination (MMSE)8,9; constipation and orthostatic hypotension by means of the Scale for Outcomes in Parkinson’s disease-Autonomic (SCOPA-AUT)7; depressive symptoms, by means of the Hamilton Rating Scale for Depression (HAM-D).10

At the original enrolment,5 each patient provided a venous blood sample, which was processed to isolate CD4+ T cells, according to an established procedure.6

Subjects with iRBD were followed prospectively with periodic in-person evaluations to diagnose phenoconversion, i.e., parkinsonism, DLB and MSA.

Isolation of CD4+ T Cells

Peripheral blood mononuclear cells were separated by Ficoll-Paque Plus density gradient centrifugation; then CD4+ T cells were obtained by immunomagnetic sorting. Cell viability was 95% ± 1% (range, 90%–98%), and purity was 98% ± 2% (range, 97%–100%). Expression of the TF genes TBX21, STAT1, STAT3, STAT4, STAT6, RORC, GATA3, FOXP3, and NR4A2 was measured by real-time polymerase chain reaction.

Real-time polymerase chain reaction assay

For real-time PCR assays of CD4+ T cells, at least 50,000 CD4+ T cells were resuspended in PerfectPure RNA lysis buffer (5 Prime GmbH, Hamburg, Germany), and total RNA was extracted by PerfectPure RNA Cell Kit™ (5 Prime GmbH, code 2302340). The amount of extracted RNA was estimated by spectrophotometry at λ = 260 nm. Total mRNA was then reverse-transcribed using a random primer and a high-capacity cDNA RT kit (Applied Biosystems, code 4368813), and the resulting amount of cDNA was estimated by spectrophotometry at λ = 260 nm. Real-Time PCR reactions were then started with 1 μM cDNA. At the beginning, we always loaded 1 μg/μl of cDNA per reaction (final reaction mix volume + sample = 20 μl). This means that for each reaction we load 2 μl of aqueous solution containing the cDNA (therefore, 2 μg of cDNA in total). The following thermal protocol was used for each sample: 20 s at 95°C (x 1, hot start); 2-step cycles as follows: 1 s at 95°C, 20 s at 60°C (x 40). All the reagents (probes and mix) were used according to the manufacturer’s instructions (www.bio-rad.com).

Ethics and consent

Ethical approval and consent were not required.

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 10 Jul 2025
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Pinoli M, Terzaghi M, Marino F et al. CD4+ T-cell transcription factors as early predictors of phenoconversion in idiopathic rapid eye movement sleep behaviour disorder [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2025, 14:683 (https://doi.org/10.12688/f1000research.163212.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 06 Oct 2025
Revised
Views
1
Cite
Reviewer Report 07 Oct 2025
Tommaso Schirinzi, University of Rome Tor Vergata, Via Cracovia, Roma, Italy 
Approved
VIEWS 1
No comments, The ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Schirinzi T. Reviewer Report For: CD4+ T-cell transcription factors as early predictors of phenoconversion in idiopathic rapid eye movement sleep behaviour disorder [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2025, 14:683 (https://doi.org/10.5256/f1000research.188922.r420597)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 10 Jul 2025
Views
8
Cite
Reviewer Report 17 Sep 2025
Adawiya J. Haider, University of Technology, Baghdad, Baghdad, Iraq 
Approved with Reservations
VIEWS 8
1. The title needs revision; should the name match the content of the text paper?
2-Abstract: not clear and should be more scientific and include some of the results in this paper.
3- The introduction needs expansion in ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Haider AJ. Reviewer Report For: CD4+ T-cell transcription factors as early predictors of phenoconversion in idiopathic rapid eye movement sleep behaviour disorder [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2025, 14:683 (https://doi.org/10.5256/f1000research.179522.r411090)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 01 Oct 2025
    Monica Pinoli, University of Insubria, Varese, Italy
    01 Oct 2025
    Author Response
    Dear Dr. Haider,
    Thank you for your valuable suggestions that provided us with insights to improve our manuscript.
    1. The title needs revision → The title has been modified to ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 01 Oct 2025
    Monica Pinoli, University of Insubria, Varese, Italy
    01 Oct 2025
    Author Response
    Dear Dr. Haider,
    Thank you for your valuable suggestions that provided us with insights to improve our manuscript.
    1. The title needs revision → The title has been modified to ... Continue reading
Views
19
Cite
Reviewer Report 23 Aug 2025
Tommaso Schirinzi, University of Rome Tor Vergata, Via Cracovia, Roma, Italy 
Approved
VIEWS 19
This manuscript presented a full dataset including clinical and biological data derived from iRBD patients who eventually converted to PD. 
The effort is valuable and the methodological issues are pretty addressed. 
I suggest avoiding repeating the RBD abbreviation ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Schirinzi T. Reviewer Report For: CD4+ T-cell transcription factors as early predictors of phenoconversion in idiopathic rapid eye movement sleep behaviour disorder [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2025, 14:683 (https://doi.org/10.5256/f1000research.179522.r399771)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 01 Oct 2025
    Monica Pinoli, University of Insubria, Varese, Italy
    01 Oct 2025
    Author Response
    Dear Dr. Schirinzi,
    we want to thank you for your suggestions, that help us to improve our manuscript.
    1. Avoiding repeating the RBD abbreviation → Repetition of abbreviations have
    ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 01 Oct 2025
    Monica Pinoli, University of Insubria, Varese, Italy
    01 Oct 2025
    Author Response
    Dear Dr. Schirinzi,
    we want to thank you for your suggestions, that help us to improve our manuscript.
    1. Avoiding repeating the RBD abbreviation → Repetition of abbreviations have
    ... Continue reading

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 10 Jul 2025
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.